Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

523
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
523
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

254
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
254
Neural Regulation01:37

Neural Regulation

39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

507
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
507
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

179
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
179

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of DSA-based Cerebral Microcirculation Time on Neurological Improvement at Discharge in Stroke Patients after Successful Recanalization.

AJNR. American journal of neuroradiology·2026
Same author

Proteomic insights into the combined effects of near-threshold bleaching temperature and prometryn exposure on the coral Galaxea fascicularis.

Marine environmental research·2026
Same author

Occurrence, seasonal variability, and ecological risk of emerging contaminants in estuarine and nearshore waters around Hainan Island, China.

Marine environmental research·2026
Same author

Development and validation of a nomogram for predicting heterogeneous patient-reported outcome recovery trajectories after lung cancer surgery: a retrospective study.

Journal of cardiothoracic surgery·2026
Same author

Multi-omics analysis reveals NSUN2-mediated m5C methylation of DOCK9 regulating vascular stability in brain arteriovenous malformations.

Cell reports·2026
Same author

Flexible and fast inscription of parallel-integrated fiber Bragg gratings by femtosecond laser through spatial light modulation.

Optics express·2026

Related Experiment Video

Updated: Jun 22, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.7K

Parkinsonism in liver diseases or dysfunction.

Sichen Li1, Yuxia Zhua1, Xi Liu1

  • 1Department of Neurology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Medicina Clinica
|July 2, 2024
PubMed
Summary

Parkinsonism linked to liver dysfunction presents unique clinical features and mechanisms, including metal overload and neurotoxicity. Understanding these factors aids in diagnosis and management of this atypical neurological condition.

Keywords:
Diagnóstico diferencialDifferential diagnosisEnfermedad hepáticaLiver diseaseMecanismoMechanismParkinsonismParkinsonismo

More Related Videos

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.7K

Related Experiment Videos

Last Updated: Jun 22, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.7K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.7K

Area of Science:

  • Neurology
  • Hepatology
  • Neurotoxicology

Background:

  • Parkinsonism is a recognized neurological manifestation in patients with liver diseases or dysfunction.
  • This condition encompasses neurological symptoms in hereditary liver diseases and complications of advanced liver disease.
  • It can manifest as isolated akinetic-rigidity syndrome or alongside other movement disorders.

Purpose of the Study:

  • To summarize the shared clinical features of parkinsonism associated with liver disease or dysfunction.
  • To elucidate the underlying pathophysiological mechanisms contributing to this neurological condition.
  • To propose a practical flowchart for the differential diagnosis of liver disease-associated parkinsonism.

Main Methods:

  • Review of existing literature on neurological manifestations in liver diseases.
  • Analysis of clinical presentations, including onset, progression, and response to treatment (e.g., levodopa).
  • Examination of neuroimaging and serum biomarker data reflecting metabolic abnormalities.

Main Results:

  • Parkinsonism in liver disease is characterized by akinetic-rigidity syndrome, variable progression, and poor levodopa response.
  • Metabolic abnormalities, evident in biomarkers and neuroimaging, are key indicators.
  • Pathways involve susceptibility of basal ganglia to toxic insults (manganese, iron, copper, ammonia), oxidative stress, and neurotransmitter imbalance.

Conclusions:

  • Parkinsonism in liver dysfunction arises from impaired liver clearance leading to neurotoxic insults.
  • Interrelated mechanisms including oxidative stress and glial-neuronal imbalance contribute to neurotoxicity.
  • Recognizing these distinct features and mechanisms is crucial for accurate clinical diagnosis and management.